IQVIA HOLDINGS INC. (IQV)
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Sector: Services-Commercial Physical & Biological Research
Industry: Medical - Diagnostics & Research
IQVIA Holdings Inc.
NYSE:IQVHealthcare · Medical - Diagnostics & Research
-2.81%$267.33
AH$267.33+0.00%vs close
Mkt Cap$44.06B
Float149.57M
O/S164.8M
Vol
$ Vol
RVOL
Inst Own94.3%
SI2.0%
Earnings
Dilution
Financials Summary
Revenue$16.31B
Net Income$1.36B
Total Assets$29.94B
Free Cash Flow$2.05B
Debt & Equity
Debt 71%
Equity 29%
Total Debt$16.17B
Total Equity$6.5B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in IQV's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$29.94B
Liabilities$23.31B
Accounts Receivable$3.43B
Accounts Payable$3.75B
Inventory$0
PP&E (Net)$823M
Goodwill$16.62B
Intangible Assets$4.96B
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
| Revenue | $16.31B | $15.4B | $14.98B | $14.41B | $13.87B | $11.36B | $11.09B | $10.41B | $9.7B | $6.82B | $5.74B | $5.46B | $5.1B | $4.87B | $4.33B | $3.92B |
| YoY Growth | 5.9% | 2.8% | 4.0% | 3.9% | 22.1% | 2.4% | 6.5% | 7.3% | 42.4% | 18.8% | 5.1% | 7.1% | 4.8% | 12.4% | 10.3% | - |
| Cost of Revenue | $10.88B | $10.03B | $9.74B | $9.38B | $9.23B | $7.5B | $7.3B | $6.75B | $6.3B | $4.75B | $4.12B | $3.96B | $3.76B | $3.63B | $3.19B | $2.8B |
| Gross Profit | $5.43B | $5.38B | $5.24B | $5.03B | $4.64B | $3.86B | $3.79B | $3.67B | $3.4B | $2.07B | $1.62B | $1.5B | $1.34B | $1.23B | $1.14B | $1.12B |
| Gross Margin | 33.3% | 34.9% | 35.0% | 34.9% | 33.5% | 34.0% | 34.2% | 35.2% | 35.1% | 30.3% | 28.3% | 27.5% | 26.2% | 25.3% | 26.4% | 28.5% |
| Research and Development | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.34M | $0 | $4.96M | $10.43M | $0 | $0 |
| Selling, General, and Administrative | $1.99B | $1.99B | $2.05B | $2.07B | $1.96B | $1.79B | $1.73B | $1.72B | $1.6B | $1.01B | $920.99M | $882.34M | $830.21M | $817.75M | $762.3M | $698.41M |
| Other | $1.26B | $1.18B | $1.21B | $1.16B | $1.28B | $1.34B | $1.28B | $1.21B | $1.11B | $475M | $160M | $130M | $14.07M | $18.74M | $34.41M | $25.77M |
| Total Operating Expenses | $3.25B | $3.17B | $3.26B | $3.23B | $3.25B | $3.13B | $3.01B | $2.92B | $2.74B | $1.49B | $975M | $911M | $874.58M | $836.5M | $796.71M | $724.18M |
| Operating Income (EBIT) | $2.18B | $2.2B | $1.98B | $1.8B | $1.39B | $731M | $777M | $741M | $719M | $642M | $646.61M | $590.39M | $462.33M | $396.44M | $345.25M | $395M |
| Operating Margin | 13.4% | 14.3% | 13.2% | 12.5% | 10.0% | 6.4% | 7.0% | 7.1% | 7.4% | 9.4% | 11.3% | 10.8% | 9.1% | 8.1% | 8.0% | 10.1% |
| Interest Expense | $729M | $670M | $672M | $416M | $375M | $416M | $447M | $414M | $346M | $144M | $101.79M | $100.59M | $123.51M | $134.37M | $109.06M | $141.43M |
| Interest Income | $45M | $47M | $36M | $13M | $6M | $6M | $9M | $8M | $7M | $4M | $4.32M | $3.41M | $3.94M | $3.07M | $3.94M | $3.8M |
| Other Income (Expense) | -$569M | -$533M | -$518M | -$448M | -$259M | -$351M | -$434M | -$398M | -$361M | -$164M | -$99M | -$89M | -$139.22M | -$145.18M | -$126.13M | -$153.28M |
| Income Before Tax (EBT) | $1.61B | $1.67B | $1.46B | $1.35B | $1.13B | $380M | $343M | $343M | $304M | $412M | $547M | $506M | $323.12M | $270M | $255.43M | $241.73M |
| Income Tax Expense | $252M | $296M | $101M | $260M | $163M | $72M | $116M | $59M | -$987M | $345M | $158.99M | $150.06M | $95.97M | $93.36M | $15.11M | $77.58M |
| Net Income | $1.36B | $1.37B | $1.36B | $1.09B | $966M | $279M | $191M | $259M | $1.31B | $115M | $387.2M | $356.38M | $226.59M | $177.55M | $241.77M | $160.6M |
| Net Income Margin | 8.3% | 8.9% | 9.1% | 7.6% | 7.0% | 2.5% | 1.7% | 2.5% | 13.5% | 1.7% | 6.7% | 6.5% | 4.4% | 3.6% | 5.6% | 4.1% |
| Supplementary Data | ||||||||||||||||
| EPS | 7.91 | 7.57 | 7.39 | 5.82 | 5.05 | 1.46 | 0.98 | 1.27 | 6.01 | 0.77 | 3.15 | 2.78 | 1.83 | 1.42 | 1.93 | 1.28 |
| Diluted EPS | 7.84 | 7.49 | 7.29 | 5.72 | 4.95 | 1.43 | 0.96 | 1.24 | 5.88 | 0.76 | 3.08 | 2.72 | 1.77 | 1.39 | 1.90 | 1.26 |
| Weighted Average OS | 171.90M | 181.30M | 183.80M | 187.60M | 191.40M | 191.30M | 195.10M | 203.70M | 217.80M | 149.10M | 123.04M | 127.99M | 124.15M | 125.47M | 125.47M | 125.47M |
| EBITDA | $2.94B | $3.45B | $3.26B | $2.91B | $2.77B | $2.08B | $2B | $1.88B | $1.65B | $849M | $768M | $723M | $554.13M | $500.09M | $385.74M | $467.37M |
| EBITDA Margin | 18.0% | 22.4% | 21.7% | 20.2% | 19.9% | 18.3% | 18.0% | 18.1% | 17.0% | 12.5% | 13.4% | 13.2% | 10.9% | 10.3% | 8.9% | 11.9% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $1.98B | $1.7B | $1.38B | $1.22B | $1.37B | $1.81B | $837M | $891M | $959M | $1.2B | $977.15M | $867.36M | $778.14M | $567.73M | $516.3M |
| Short-Term Investments | $161M | $141M | $120M | $93M | $111M | $88M | $62M | $47M | $46M | $40M | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $2.14B | $1.84B | $1.5B | $1.31B | $1.48B | $1.9B | $899M | $938M | $1B | $1.24B | $977.15M | $867.36M | $778.14M | $567.73M | $516.3M |
| Accounts Receivable | $3.43B | $3.24B | $3.41B | $2.96B | $2.61B | $2.47B | $2.64B | $2.46B | $2.14B | $1.74B | $1.2B | $1.02B | $940.38M | $837.05M | $716.49M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $519M | $592M | $546M | $561M | $521M | $563M | $451M | $322M | $259M | $235M | $181.89M | $213.49M | $184.37M | $145.94M | $46.71M |
| Total Current Assets | $6.25B | $5.83B | $5.6B | $4.98B | $4.76B | $5.09B | $4.13B | $3.87B | $3.55B | $3.34B | $2.41B | $2.15B | $1.95B | $1.51B | $1.37B |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $823M | $773M | $819M | $863M | $903M | $953M | $954M | $434M | $440M | $406M | $188.39M | $190.3M | $199.58M | $194M | $185.77M |
| Goodwill | $16.62B | $14.71B | $14.57B | $13.92B | $13.3B | $12.65B | $12.16B | $11.8B | $11.85B | $10.73B | $719.74M | $464.43M | $409.63M | $302.43M | $278.04M |
| Intangible Assets | $4.96B | $4.5B | $4.84B | $4.82B | $4.94B | $5.21B | $5.51B | $5.95B | $6.59B | $6.39B | $368.11M | $280.24M | $298.05M | $272.81M | $269.41M |
| Long-Term Investments | $432M | $374M | $239M | $162M | $164M | $162M | $152M | $142M | $78M | $82M | $85.29M | $66.01M | $63.28M | $55.1M | $33.89M |
| Deferred Tax Assets | $357M | $194M | $166M | $118M | $124M | $114M | $119M | $109M | $98M | $89M | $42.68M | $35.97M | $32.86M | $37.31M | $78.18M |
| Other Long-Term Assets | $505M | $520M | $455M | $472M | $491M | $386M | $227M | $239M | $235M | $177M | $110.11M | $122.79M | $117.71M | $127.51M | $112.15M |
| Total Long-Term Assets | $23.7B | $21.07B | $21.09B | $20.36B | $19.93B | $19.47B | $19.13B | $18.68B | $19.29B | $17.87B | $1.51B | $1.16B | $1.12B | $989.16M | $957.44M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $29.94B | $26.9B | $26.68B | $25.34B | $24.69B | $24.56B | $23.25B | $22.55B | $22.74B | $21.21B | $3.93B | $3.31B | $3.07B | $2.5B | $2.32B |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $3.75B | $736M | $709M | $645M | $621M | $581M | $2.51B | $437M | $322M | $250M | $145.48M | $108.74M | $100.62M | $84.71M | $70.03M |
| Short-Term Debt | $1.84B | $1.15B | $718M | $152M | $91M | $149M | $100M | $100M | $103M | $92M | $48.51M | $826K | $10.43M | $55.71M | $20.15M |
| Current Income Tax Payable | $0 | $156M | $116M | $161M | $137M | $102M | $108M | $100M | $72M | $76M | $35.17M | $55.69M | $35.78M | $9.64M | $47.04M |
| Current Unearned Revenue | $2.12B | $1.78B | $1.8B | $1.8B | $1.82B | $1.25B | $1.01B | $1.01B | $733M | $774M | $584.65M | $543.3M | $538.59M | $456.59M | $398.47M |
| Other Current Liabilities | $489M | $1.1B | $1.26B | $1.13B | $1.15B | $1.09B | $211M | -$1.17B | $666M | $630M | $420M | $432.94M | $472.78M | $404.88M | $362.71M |
| Total Current Liabilities | $8.34B | $6.96B | $6.49B | $5.58B | $5.24B | $4.56B | $3.94B | $3.53B | $2.9B | $2.71B | $1.59B | $1.47B | $1.48B | $1.32B | $1.19B |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $14.11B | $12.84B | $12.96B | $12.6B | $12.03B | $12.38B | $11.54B | $10.91B | $10.12B | $7.11B | $2.42B | $2.28B | $2.04B | $2.37B | $1.95B |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $179M | $196M | $202M | $464M | $410M | $338M | $646M | $736M | $918M | $2.13B | $65.7M | $61.8M | $37.54M | $11.62M | $9.87M |
| Other Long-Term Liabilities | $463M | $668M | $698M | $671M | $649M | $633M | $456M | $418M | $440M | $402M | $183M | $183.66M | $178.91M | $171.32M | $138.81M |
| Total Long-Term Liabilities | $14.98B | $13.88B | $14.08B | $13.99B | $13.41B | $13.73B | $13.04B | $12.06B | $11.48B | $9.64B | $2.67B | $2.54B | $2.25B | $2.54B | $2.1B |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $23.31B | $20.83B | $20.57B | $19.57B | $18.65B | $18.28B | $16.99B | $15.6B | $14.38B | $12.35B | $4.26B | $4.01B | $3.73B | $3.86B | $3.29B |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $11.38B | $3M | $3M | $10.9B | $3M | $3M | $11.05B | $10.9B | $10.78B | $10.6B | $8.78M | $143.83M | $478.14M | $4.55M | $1.16M |
| Retained Earnings | $7.42B | $6.07B | $4.69B | $3.33B | $2.24B | $1.28B | $998M | $807M | $655M | -$399M | -$461.63M | -$788.8M | -$1.15B | -$1.37B | -$994.41M |
| Comprehensive Income & Other | -$943M | -$1.04B | -$867M | -$727M | -$406M | -$205M | -$311M | -$224M | $46M | -$570M | -$111.37M | -$59.09M | -$376K | $7.7M | $22.87M |
| Other Stockholders' Equity | -$12.3B | -$1M | $1.42B | -$8.47B | $3.8B | $4.72B | -$6.04B | -$4.99B | -$3.33B | -$1.57B | $117.17M | -$59.04M | -$376K | $7.7M | $22.87M |
| Total Equity | $6.5B | $6.07B | $6.11B | $5.76B | $6.04B | $6B | $6B | $6.71B | $8.11B | $8.63B | -$335.68M | -$704.01M | -$667.41M | -$1.36B | -$970.38M |
| Minority Interest | $127M | $0 | $0 | $0 | $0 | $279M | $260M | $240M | $249M | $227M | $228.54M | $49K | -$72K | $479K | $788K |
| Total Liabilities and Equity | $29.82B | $26.9B | $26.68B | $25.34B | $24.69B | $24.29B | $22.99B | $22.31B | $22.49B | $20.98B | $3.93B | $3.31B | $3.07B | $2.5B | $2.32B |
| Supplementary Data | |||||||||||||||
| Total Debt | $16.17B | $14.16B | $13.9B | $13.01B | $12.44B | $12.9B | $12.04B | $11.01B | $10.22B | $7.2B | $2.47B | $2.29B | $2.05B | $2.42B | $1.97B |
| Net Debt | $14.19B | $12.45B | $12.52B | $11.79B | $11.07B | $11.09B | $11.2B | $10.12B | $9.27B | $6B | $1.49B | $1.43B | $1.27B | $1.85B | $1.46B |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
| Operating Activities | ||||||||||||||||
| Net Income | $1.36B | $1.37B | $1.36B | $1.09B | $966M | $308M | $227M | $284M | $1.33B | $130M | $388.3M | $356.5M | $226.03M | $176.63M | $240.33M | $165.25M |
| Depreciation & Amortization | $1.14B | $1.11B | $1.13B | $1.13B | $1.26B | $1.29B | $1.2B | $1.14B | $1.01B | $289M | $127.74M | $121.01M | $107.5M | $98.29M | $92M | $84.22M |
| Deferred Income Tax | -$180M | -$129M | -$269M | -$115M | -$138M | -$176M | -$157M | -$177M | -$1.22B | $135M | $18.35M | -$6.17M | -$24.24M | $16.59M | -$73.22M | -$9.01M |
| Stock-Based Compensation | $247M | $206M | $217M | $194M | $170M | $95M | $146M | $113M | $106M | $80M | $37.76M | $30M | $22.83M | $25.93M | $14.13M | $17.33M |
| Changes in Working Capital: | ||||||||||||||||
| Accounts Receivable | $60M | $182M | -$388M | -$421M | -$138M | $255M | -$124M | -$297M | -$142M | -$62M | -$246.03M | -$78.63M | -$151.68M | -$60.26M | -$115.75M | $2.75M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | -$116M | -$184M | -$136M | $62M | $18.87M | -$32.98M | $32.56M | -$40.13M | $18.24M | -$20.7M |
| Accounts Payable | -$96M | $115M | $267M | $427M | $244M | $253M | $240M | $368M | $90M | $160M | $104.35M | $45.8M | $107.05M | $58.34M | $67.38M | $38.91M |
| Other Working Capital | $161M | -$139M | -$159M | -$90M | $574M | -$49M | $19M | $7M | -$104M | $52M | $53.85M | $19.94M | $71.85M | $54.5M | -$52.42M | $82.33M |
| Total Working Capital Change | $125M | $158M | -$280M | -$84M | $680M | $459M | $19M | -$106M | -$292M | $212M | -$68.97M | -$45.86M | $59.78M | $12.46M | -$82.55M | $103.3M |
| Other Non-Cash Items | -$43M | -$6M | -$2M | $44M | $0 | -$14M | -$20M | -$1M | $33M | $14M | -$27.5M | -$23.73M | $5.47M | $5.8M | -$29.75M | $17.06M |
| Net Cash from Operating | $2.65B | $2.72B | $2.15B | $2.26B | $2.94B | $1.96B | $1.42B | $1.25B | $970M | $860M | $475.69M | $431.75M | $397.37M | $335.7M | $160.95M | $378.16M |
| Investing Activities | ||||||||||||||||
| Capital Expenditures | -$603M | -$602M | -$649M | -$674M | -$640M | -$616M | -$582M | -$459M | -$369M | -$164M | -$78.39M | -$82.65M | -$92.35M | -$71.34M | -$75.68M | -$80.24M |
| Acquisitions | -$1.76B | -$710M | -$876M | -$1.33B | -$1.46B | -$167M | -$588M | -$326M | -$827M | $1.87B | $19.38M | -$96.67M | -$149.99M | -$47.42M | -$135.82M | -$101.87M |
| Purchases of Investments | -$20M | -$134M | -$83M | -$5M | -$15M | -$11M | -$25M | -$27M | $2M | -$40M | -$10.98M | $1.61M | -$314K | -$13.37M | -$32.68M | -$7.06M |
| Sales of Investments | $2M | $0 | $0 | $0 | $5M | $0 | -$22M | $459M | $2M | $41M | $2.49M | $5.86M | $2.33M | $70K | $2.98M | $21.7M |
| Other Investing Activities | $74M | $2M | $5M | $8M | $5M | -$2M | $27M | -$457M | $2M | $24M | $551K | -$1.26M | $138K | -$182K | $16.37M | $26.04M |
| Net Cash from Investing | -$2.31B | -$1.44B | -$1.6B | -$2.01B | -$2.1B | -$796M | -$1.19B | -$810M | -$1.19B | $1.73B | -$66.95M | -$173.11M | -$240.18M | -$132.23M | -$224.84M | -$141.43M |
| Financing Activities | ||||||||||||||||
| Debt Repaid | -$1.21B | -$553M | -$1.13B | -$616M | -$70M | -$727M | -$1B | -$899M | -$2.36B | $1.32B | -$188M | -$242M | $387.66M | -$440.14M | -$260.12M | $78.36M |
| Common Stock Issuance | -$67M | $0 | $0 | $0 | $0 | $0 | $0 | $15M | $91M | $97M | $0 | $0 | $525M | $3.12M | $0 | $67K |
| Common Stock Repurchases | -$1.24B | -$1.35B | -$992M | -$1.17B | -$406M | -$447M | -$949M | -$1.41B | -$2.62B | -$1.1B | -$515.01M | -$415M | -$6.43M | -$13.36M | -$14.32M | -$9.34M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$567.85M | -$288.32M | -$67.49M |
| Other Financing Activities | -$44M | -$81M | -$192M | -$102M | -$899M | -$112M | -$74M | -$62M | $37M | $126M | $77.75M | $42.66M | $465.05M | -$8.91M | -$16.78M | $2.05M |
| Net Cash from Financing | -$150M | -$878M | -$382M | -$329M | -$1.24B | -$217M | -$276M | -$452M | -$72M | -$2.28B | -$249.25M | -$130.34M | $70.96M | -$146.87M | -$59.31M | -$153.08M |
| Forex Effect | $79M | -$68M | -$4M | -$75M | -$52M | $31M | -$5M | -$60M | $53M | -$86M | -$49.7M | -$39.08M | -$17.74M | -$5.17M | -$7.12M | -$2.8M |
| Net Change in Cash | $278M | $326M | $160M | -$150M | -$448M | $977M | -$54M | -$68M | -$239M | $221M | $109.79M | $89.22M | $210.41M | $51.43M | -$130.32M | $80.84M |
| Supplementary Data | ||||||||||||||||
| Operating Cash Flow | $2.65B | $2.72B | $2.15B | $2.26B | $2.94B | $1.96B | $1.42B | $1.25B | $970M | $860M | $475.69M | $431.75M | $397.37M | $335.7M | $160.95M | $378.16M |
| Capital Expenditure | -$603M | -$602M | -$649M | -$674M | -$640M | -$616M | -$582M | -$459M | -$369M | -$164M | -$78.39M | -$82.65M | -$92.35M | -$71.34M | -$75.68M | -$80.24M |
| Free Cash Flow | $2.05B | $2.11B | $1.5B | $1.59B | $2.3B | $1.34B | $835M | $795M | $601M | $696M | $397.3M | $349.1M | $305.02M | $264.37M | $85.27M | $297.92M |
| Cash at Beginning | $1.7B | $1.38B | $1.22B | $1.37B | $1.81B | $837M | $891M | $959M | $1.2B | $977M | $867.36M | $778.14M | $567.73M | $516.3M | $646.62M | $565.77M |
| Cash at End | $1.98B | $1.7B | $1.38B | $1.22B | $1.37B | $1.81B | $837M | $891M | $959M | $1.2B | $977.15M | $867.36M | $778.14M | $567.73M | $516.3M | $646.62M |